KLP Kapitalforvaltning’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$171K Hold
15,600
﹤0.01% 1946
2026
Q1
$127K Hold
15,600
﹤0.01% 1980
2025
Q4
$162K Sell
15,600
-3,400
-18% -$35.7K ﹤0.01% 1909
2025
Q3
$168K Hold
19,000
﹤0.01% 1886
2025
Q2
$110K Buy
19,000
+12,200
+179% +$74.7K ﹤0.01% 2016
2025
Q1
$44.9K Sell
6,800
-7,800
-53% -$60.8K ﹤0.01% 2202
2024
Q4
$127K Buy
+14,600
New +$210K ﹤0.01% 2005

Other funds holding KURA

KLP Kapitalforvaltning's KURA Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Kura Oncology (KURA) position steady in Q2 2026 at 15,600 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #1946.

KLP Kapitalforvaltning first reported a position in KURA in Q4 2024 and has held it in 7 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • KLP Kapitalforvaltning held 15,600 shares of Kura Oncology worth $171K as of Q2 2026.
  • KLP Kapitalforvaltning left its Kura Oncology share count unchanged in Q2 2026.
  • Kura Oncology made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1946 holding.
  • KLP Kapitalforvaltning first reported a position in Kura Oncology in Q4 2024 and has held it in 7 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.